Sneakerheads have exciting news from Nike as the brand is planning to launch the Nike Air Max 95 “Cool Grey” sneakers.

It should come as no surprise that the Eastern Bloc powers came up with their own aerial counterparts to the A-10. Though the Republic Fairchild A-10 Thunderbolt II, far better known by its unofficial ...

One reviewer says, "Absolutely love these trainers! The advice to size up half a size is bang on. Would definitely recommend them." Another reviewer says, "These are some comfortable sneakers to walk ...

The "Black/Red/White" version of Nike Air Max Plus sneakers maintains all its original elements and brings together striking color contrasts to create a fresh design. The upper showcases a ...

The Women’s Air Jordan 5 Golden Ticket is out now for a retail price of $200. Pick up a pair via the Nike SNKRS app.

If you’re looking for a thriller movie that will stay with you long after the credits roll, “Buried” deserves to be on your ...

Max Mqadi, the founder and owner of the popular Max’s Lifestyle in Umlazi, has come under fire for stating that his establishment does not cater for walk-in customers. The comments, made during ...

Nike has reportedly set the stage for an upcoming Air Max 90 “Mandarin” sneakers scheduled to release in Spring 2025. This new addition to the Nike Air Max lineup brings a bold color palette, material ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...